98%
921
2 minutes
20
Background: Acute kidney injury (AKI) is common in children with congenital heart disease following open-heart surgery with cardiopulmonary bypass (CPB). Early AKI detection in critically ill children requires clinician expertise to compile various data from different sources within a stressful and time-sensitive environment. However, as electronic health records provide data in a machine-readable format, this process could be supported by computerized systems. Therefore, we developed a time-aware, rule-based clinical decision support system (CDSS) to detect, stage, and track temporal AKI progression in children.
Methods: We integrated retrospective clinical routine data from n = 290 randomly selected cases (n = 263 patients, aged 0-17 years) who underwent cardiac surgery with CPB into a dataset. We adapted Kidney Disease: Improving Global Outcome (KDIGO) criteria, including serum creatinine, urine output, and estimated glomerular filtration rate, and translated them into computable rules for the CDSS. As a reference standard, patients were manually assessed by blinded clinical experts.
Results: The AKI incidence, according to the reference standard, was n = 146 cases for stage 1, n = 58 for stage 2, and n = 20 for stage 3. The CDSS achieved sensitivities of 92.2 % (95 % CI: 86.8-95.5 %) for AKI stage 1, 88.1 % (95 % CI: 77.2-94.2 %) for stage 2, and 95 % (95 % CI: 70.5-99.3 %) for stage 3. The specificities were 97.0 % (95 % CI: 94.4-98.4 %), 98.5 % (95 % CI: 96.5-99.4 %), and 99.3 % (95 % CI: 97.3-99.8 %), respectively.
Conclusions: We demonstrated that a CDSS is able to perform a complex AKI detection and staging process, including 11 criteria across three stages. For accurate automated AKI detection, standardized machine-readable data of high data quality are required. CDSS with high diagnostic accuracy, like presented, can support clinical management and be used for surveillance and quality management. The prototypical use for surveillance and further studies, such as the development of prediction models, should demonstrate the system's benefits in the future.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.compbiomed.2025.110382 | DOI Listing |
Talanta
September 2025
School of Pharmaceutical Science, Zhengzhou University, Zhengzhou, 450001, China; Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou, 450001, China. Electronic address:
Acute kidney injury (AKI) is a swiftly advancing condition that may result in kidney failure and pose a significant threat to life. Therefore, diagnosis of AKI is crucial for treating AKI and preventing the worsening of the condition. We developed a near-infrared fluorescent probe, CyO@CD-Ser, designed for the diagnosis of AKI.
View Article and Find Full Text PDFGen Physiol Biophys
September 2025
Department of Respiratory and Critical Care Medicine, Lishui Second People's Hospital, Lishui, China.
Circular RNA (circRNA) has been confirmed to be a regulator for septic acute kidney injury (AKI). It is reported that circ_0049271 has abnormal expression in AKI patients, but its role and mechanism in septic AKI remain unclear. Lipopolysaccharide (LPS)-stimulated HK-2 cells were served as the cellular model of sepsis-associated AKI (SAKI).
View Article and Find Full Text PDFCureus
August 2025
Anesthesia and Critical Care, Hôpital Universitaire International Cheikh Khalifa Ibn Zaid/Faculty of Medicine, Mohammed VI University of Health Sciences, Casablanca, MAR.
Acyclovir is a widely used antiviral medication known for its potential nephrotoxic effects. These adverse effects may include acute kidney injury (AKI), acute tubulointerstitial nephritis, crystal-induced nephropathy, and, in rare cases, tubular dysfunction. While acyclovir is generally considered safe, nephrotoxicity can occur, particularly when administered at high doses or in dehydrated patients.
View Article and Find Full Text PDFFront Med (Lausanne)
August 2025
Department of Pathology, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China.
Background: Castleman disease (CD) is a group of rare and complicated diseases characterized by systemic inflammation, lymphadenopathy, and multiorgan involvement. It is often misdiagnosed as an infection, an autoimmune disease, or a malignant cancer.
Case Presentation: In this case, we report a 33-year-old Chinese male patient who was diagnosed with idiopathic multicentric Castleman disease (iMCD).
Curr Opin Nephrol Hypertens
September 2025
Division of Nephrology, Hypertension, and Renal Transplantation, Department of Medicine, College of Medicine.
Purpose Of Review: Artificial intelligence is continuously and rapidly evolving. Artificial intelligence has the potential to address several clinical challenges associated with the prevention, detection, and management of acute kidney injury (AKI). This review provides an overview of the state of artificial intelligence for AKI decision-making, highlighting key recent developments, trends, and innovations towards real-world bedside deployment.
View Article and Find Full Text PDF